Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery
March 19, 2025
Creates one of the largest, most comprehensive clinical genomic datasets of its kind; multiomic data to be added in next phase of program AGD members are using the population-level insights to uncover novel drug targets SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC (NashBio), a leading clinical and genomic data company and wholly [...]
Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo
March 19, 2025
Integration of the NVIDIA BioNeMo platform enhances AI capabilities across the drug discovery lifecycle Baltimore, MD – Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This integration brings AI-driven computational drug discovery directly into Sapio ELN (Electronic Lab Notebook), helping to streamline workflows and improve decision-making in [...]
Xcell Biosciences and Royal Perth Hospital to Develop Next Gen Automated TIL Manufacturing Workflow
March 18, 2025
Teams will collaborative to create an innovative TIL process on the AVATAR™ Foundry platform to enhance TILquality, quantity, and potency MELBOURNE, Australia & PERTH, Australia -- Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell and gene therapy applications, and Royal Perth Hospital announced a collaboration [...]
Beckman Coulter Life Sciences Launches Industry-First Modular Spectral Flow Cytometry Solution
March 18, 2025
CytoFLEX mosaic Spectral Detection Module Offers Up To 88 Detection Channels INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and an Operating Company of Danaher Corporation (NYSE: DHR), revolutionizes spectral flow cytometry with the industry’s first modular solution: the CytoFLEX mosaic Spectral Detection Module. When connected to the CytoFLEX [...]
March 18, 2025
SAN DIEGO -- Telesis Bio, a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, today announced that it has entered into a convertible preferred stock purchase agreement (the Purchase Agreement) to sell shares of a new series of convertible preferred stock in a private [...]
March 18, 2025
CALGARY, AB -- Nanalysis Scientific Corp. (“the Company”, TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and imaging technology and services for industrial and research applications, announces the release of automation software to reduce the barrier of expertise required to generate quantitative data. “It has long been the vision for Nanalysis to proliferate the use of [...]
Caron Scientific Unveils New Product Launch, The 7406 Incubator Shaker
March 18, 2025
MARIETTA, Ohio -- Caron Scientific, Inc., a leading provider of advanced environmental testing, incubation, and controlled environment equipment, announced today at the EU Advanced Therapies conference their newest product, the 7406 Incubator Shaker. The 7406 is the highest capacity single chamber Incubator Shaker with the smallest footprint for cell culture environments. The vertical system allows [...]
March 18, 2025
Increasing Accessibility for Flow Cytometry Applications in Emerging and Established Markets FREMONT, Calif. -- Today, Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that it has added transformative capabilities to its iconic Cytek® Guava® Muse® cell analyzer, creating a next-generation instrument called the Cytek® Muse® Micro. The Muse Micro cell analyzer is an affordable option that simplifies flow cytometry while enhancing ease-of-use, precision and [...]
March 18, 2025
BOSTON, MA, and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million patients genomic profiles analyzed on the AI-powered analytics Platform SOPHiA DDM™. This achievement solidifies SOPHiA GENETICS as the gold-standard provider of actionable insights for patient care, applying AI capabilities [...]
Confience Announces Jamey Miller as New Chief Product and Technology Officer
March 17, 2025
Confience, a leading innovator in the Laboratory Information Management System (LIMS) space, is excited to announce the appointment of Jamey Miller as its new Chief Product and Technology Officer. Mr. Miller brings a wealth of industry expertise and leadership experience. Throughout his career, he has held key leadership roles in Engineering, Product Management, Professional Services, [...]

